Workflow
INEO Retail Store Screens Now Live on Dolphin Digital's DOOH Marketplace
Newsfile· 2025-11-04 12:05
INEO Retail Store Screens Now Live on Dolphin Digital's DOOH MarketplaceNovember 04, 2025 7:05 AM EST | Source: INEO Tech Corp.Surrey, British Columbia--(Newsfile Corp. - November 4, 2025) - INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the "Company" or "INEO"), a technology leader at the intersection of in-store retail media and loss prevention, today announced the completed integration of the INEO platform with Dolphin Digital's supply-side marketplace. INEO's retail locations are now availab ...
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
Prnewswire· 2025-11-04 12:04
Accessibility StatementSkip Navigation BEIJING, Nov. 4, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has entered into an Agreement and Plan of Merger (the "Merger Agreement") with Oceanpine Skyline Inc. ("Parent") and O ...
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand
WSJ· 2025-11-04 12:04
Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral drug continue to decline. ...
Veeva Basics Adopted by More Than 100 Emerging Biotechs to Simplify and Standardize Operations
Prnewswire· 2025-11-04 12:03
Accessibility StatementSkip Navigation New applications include Veeva LIMS Basics and PromoMats Basics to drive speed and growth PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 100 biotechs have selected Veeva Basics to advance operations across clinical, regulatory, and quality. A growing number of biotechs in the U.S. and Europe are establishing a foundation for growth with a simple and standard industry-leading solution that can scale as business ...
A 10% market drawdown doesn't mean we're in a bubble, says Advisors Capital's JoAnne Feeney
Youtube· 2025-11-04 12:02
Futures taking a leg lower this morning. And joining us right now is Joanne Feny, partner and portfolio manager at Advisors Capital Management. Of course, the question Joanne is when we're talking about a bubble, every time people talk about a bubble, including myself talking about a bubble these days, whether that means we're really not in one yet or at least that it's not ready to pop.What do you think. >> Well, you know, Andrew, I don't I don't think we're in a bubble. Uh we look at, you know, history of ...
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Globenewswire· 2025-11-04 12:01
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized controlled trial in intermediate-risk NMIBC. FDA Feedback also confirms no additional non-clinical studies are required. 9-month follow-up for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety CORAL GABLES, Fla., Nov. 04, 2 ...
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
Globenewswire· 2025-11-04 12:01
Incyte secures an exclusive option to acquire Prelude’s mutant selective JAK2V617F JH2 inhibitor program Mutant selective JAK2V617F JH2 inhibitors have disease-modifying potential in treating patients living with myeloproliferative neoplasms (MPNs) Prelude to receive a $35 million upfront payment and $25 million strategic equity investment, $100 million if Incyte were to exercise the option to acquire the program, and up to $775 million in additional potential milestones plus royalties on net salesPrelude w ...
Evonik Industries AG 2025 Q3 - Results - Earnings Call Presentation (OTCMKTS:EVKIY) 2025-11-04
Seeking Alpha· 2025-11-04 12:00
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
James River posts underwriting income of $8.9m and improved CoR in Q3’25
ReinsuranceNe.ws· 2025-11-04 12:00
James River Group Holdings, Ltd., a Bermuda-domiciled insurance holding company, reported underwriting income of $8.9 million in the third quarter of 2025, compared to a loss of $56.8 million in the same period last year, with its combined ratio improving to 94.0% from 135.5%.The Q3’25 combined ratio consisted of a loss ratio of 65.7% and an expense ratio of 28.3%, compared to 104.1% and 31.4%, respectively, in Q3’24.The company posted a net loss from continuing operations available to common shareholders o ...
A solid earnings season reveals tech strength and consumer weakness
Yahoo Finance· 2025-11-04 12:00
This is The Takeaway from today's Morning Brief, which you can sign up to receive in your inbox every morning along with: What we're watching What we're reading Economic data releases and earnings In the absence of key government data, corporate earnings are even more important. This quarter's results have taken on greater importance, offering a guidepost as investors navigate ongoing trade battles, lingering inflation, and a flagging labor market. A midseason snapshot suggests corporates are humming ...